Stereotactic body radiation therapy in primary liver tumor: Local control, outcomes and toxicities.

ABSTRACT:

Objective

Stereotactic body radiation therapy (SBRT) is a therapeutic option in the guidelines for liver primaries after standard strategies like surgery or thermoablation have failed. To assess its efficacy and safety, we reviewed all patients treated by SBRT for a hepatocellular carcinoma (HCC) over a six-year period.

Methods and materials

The study included all patients treated by SBRT for HCC between April 2015 and November 2021 in the University Cancer Institute at Toulouse-Oncopole. All patients were inoperable and not eligible for thermoablation, or after a failure. All tumor sizes were included and cirrhosis up to Child-Pugh B was accepted. Local control (LC), overall survival (OS) and progression-free survival (PFS) were estimated by the Kaplan-Meier method. Treatme

SUBMITTER: Hernandez L 

PROVIDER: S-EPMC11625365 | biostudies-literature | 2025 Jan

REPOSITORIES: biostudies-literature